Bank of New York Mellon’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$820K Buy
173,830
+2,517
+1% +$11.9K ﹤0.01% 3214
2025
Q1
$786K Sell
171,313
-3,704
-2% -$17K ﹤0.01% 3177
2024
Q4
$838K Sell
175,017
-30,260
-15% -$145K ﹤0.01% 3243
2024
Q3
$963K Sell
205,277
-52,718
-20% -$247K ﹤0.01% 3152
2024
Q2
$1.46M Buy
257,995
+20,721
+9% +$117K ﹤0.01% 2973
2024
Q1
$975K Sell
237,274
-17,730
-7% -$72.9K ﹤0.01% 3161
2023
Q4
$1.08M Buy
255,004
+5,435
+2% +$22.9K ﹤0.01% 3146
2023
Q3
$1.08M Sell
249,569
-272,987
-52% -$1.18M ﹤0.01% 3106
2023
Q2
$3.44M Buy
522,556
+11,561
+2% +$76.2K ﹤0.01% 2533
2023
Q1
$3.47M Buy
510,995
+5,402
+1% +$36.7K ﹤0.01% 2497
2022
Q4
$3.74M Sell
505,593
-258,012
-34% -$1.91M ﹤0.01% 2505
2022
Q3
$7.54M Buy
763,605
+147,014
+24% +$1.45M ﹤0.01% 2072
2022
Q2
$6.72M Sell
616,591
-662,564
-52% -$7.22M ﹤0.01% 2161
2022
Q1
$14.5M Sell
1,279,155
-190,811
-13% -$2.16M ﹤0.01% 1868
2021
Q4
$23.1M Buy
1,469,966
+180,437
+14% +$2.83M ﹤0.01% 1639
2021
Q3
$22.1M Buy
1,289,529
+196,831
+18% +$3.37M ﹤0.01% 1670
2021
Q2
$23.5M Buy
1,092,698
+507,383
+87% +$10.9M ﹤0.01% 1638
2021
Q1
$8.79M Buy
585,315
+5,383
+0.9% +$80.9K ﹤0.01% 2159
2020
Q4
$7.62M Sell
579,932
-25,306
-4% -$333K ﹤0.01% 2147
2020
Q3
$5.85M Sell
605,238
-18,352
-3% -$177K ﹤0.01% 2135
2020
Q2
$7.13M Buy
623,590
+23,031
+4% +$263K ﹤0.01% 2025
2020
Q1
$6.22M Sell
600,559
-12,335
-2% -$128K ﹤0.01% 1964
2019
Q4
$10.1M Buy
612,894
+7,105
+1% +$117K ﹤0.01% 1967
2019
Q3
$8.04M Buy
605,789
+10,716
+2% +$142K ﹤0.01% 2037
2019
Q2
$8.39M Sell
595,073
-8,847
-1% -$125K ﹤0.01% 2064
2019
Q1
$11.1M Sell
603,920
-28,969
-5% -$533K ﹤0.01% 1914
2018
Q4
$16.5M Buy
632,889
+42,218
+7% +$1.1M 0.01% 1606
2018
Q3
$13.6M Buy
590,671
+376,301
+176% +$8.64M ﹤0.01% 1857
2018
Q2
$4.08M Buy
214,370
+9,796
+5% +$187K ﹤0.01% 2493
2018
Q1
$3.45M Buy
204,574
+4,213
+2% +$71K ﹤0.01% 2527
2017
Q4
$3.05M Buy
200,361
+783
+0.4% +$11.9K ﹤0.01% 2594
2017
Q3
$3.57M Buy
199,578
+3,305
+2% +$59.2K ﹤0.01% 2502
2017
Q2
$3.2M Buy
196,273
+10,331
+6% +$168K ﹤0.01% 2563
2017
Q1
$2.6M Buy
185,942
+49
+0% +$686 ﹤0.01% 2687
2016
Q4
$2.97M Buy
185,893
+9,479
+5% +$151K ﹤0.01% 2615
2016
Q3
$2.94M Sell
176,414
-18,382
-9% -$306K ﹤0.01% 2527
2016
Q2
$2.18M Sell
194,796
-4,448
-2% -$49.8K ﹤0.01% 2668
2016
Q1
$1.67M Buy
199,244
+11,658
+6% +$97.4K ﹤0.01% 2761
2015
Q4
$1.75M Sell
187,586
-19,408
-9% -$181K ﹤0.01% 2797
2015
Q3
$2.34M Sell
206,994
-24,742
-11% -$279K ﹤0.01% 2636
2015
Q2
$2.94M Buy
231,736
+11,005
+5% +$140K ﹤0.01% 2668
2015
Q1
$2.05M Buy
220,731
+6,836
+3% +$63.6K ﹤0.01% 2844
2014
Q4
$3.06M Sell
213,895
-439,653
-67% -$6.3M ﹤0.01% 2578
2014
Q3
$6.78M Sell
653,548
-1,585
-0.2% -$16.5K ﹤0.01% 2125
2014
Q2
$10.6M Buy
655,133
+142,672
+28% +$2.31M ﹤0.01% 1889
2014
Q1
$8.33M Buy
512,461
+331,872
+184% +$5.39M ﹤0.01% 2013
2013
Q4
$2.24M Sell
180,589
-75,767
-30% -$940K ﹤0.01% 2812
2013
Q3
$2.81M Buy
256,356
+95,711
+60% +$1.05M ﹤0.01% 2616
2013
Q2
$1.3M Buy
+160,645
New +$1.3M ﹤0.01% 3034